Henry-Vitrac C, Ibarra A, Roller M, Merillon JM, Vitrac X
By Drug, market is segmented by Exenatide, Liraglutide, Lixisenatide, Dulaglutide, Semaglutide, Tirzepatide, Pipeline & Biosimilar/Generic GLP-1
Biological sex is increasingly recognized as a relevant determinant, as sex-specific differences in hormone profiles, immune function, gut microbiota composition and GLP-1 RA pharmacodynamics have been associated with differences in weight-loss outcomes and gastrointestinal tolerability (127)
The shift is twofold: less volume per portion, more protein per portion
If you have been doing everything right eating well, staying active, managing your stress and the scale still will not budge, you are not failing
Science-backed weight loss In clinical studies using Saxenda, results showed that over 52 weeks (12 months)